Type m1 leukemia is acute myeloid leukemia M1, acute myeloid leukemia M1 cure rate is very low, generally around 20% ~ 30%. Acute myeloid leukemia m1 cure rate varies according to the patient’s disease progression, clinical five-year disease-free survival as the definition of cure, the general cure rate is about 20% ~ 30%. Acute myeloid leukemia m1 bone marrow morphology will appear more progranulocytes, single morphology, the proportion of cytosolic and cytoplasmic nuclei is higher, the current clinical treatment is mainly based on chemotherapy, bone marrow transplantation treatment. Commonly used chemotherapeutic drugs include Zoerythromycin, Cytarabine, etc. Nearly half of the patients may be in complete remission after chemotherapy, but many patients are still unable to go into remission after 2-3 cycles of chemotherapy, or some of them may experience relapse in a short period of time. If the patient’s bone marrow matching is successful, allogeneic hematopoietic stem cell transplantation can be completed as early as possible, but the possibility of relapse still cannot be ruled out. It is recommended that patients with AML M1 undergo standardized treatment under the guidance of a physician.